These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21186331)

  • 21. Impact of Voltage Mapping to Guide Whether to Perform Ablation of the Posterior Wall in Patients With Persistent Atrial Fibrillation.
    Cutler MJ; Johnson J; Abozguia K; Rowan S; Lewis W; Costantini O; Natale A; Ziv O
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):13-21. PubMed ID: 26515166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Outcome of Left Atrial Voltage-Guided Substrate Ablation During Atrial Fibrillation: A Novel Adjunctive Ablation Strategy.
    Yagishita A; Gimbel JR; DE Oliveira S; Manyam H; Sparano D; Cakulev I; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):147-155. PubMed ID: 27862561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biatrial substrate properties in patients with atrial fibrillation.
    Chang SL; Tai CT; Lin YJ; Wongcharoen W; Lo LW; Tuan TC; Udyavar AR; Chang SH; Tsao HM; Hsieh MH; Hu YF; Chen YJ; Chen SA
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1134-9. PubMed ID: 17764448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.
    Sun Y; Huang ZY; Wang ZH; Li CP; Meng XL; Zhang YJ; Su F; Ma N
    Mol Cell Biochem; 2015 Aug; 406(1-2):131-8. PubMed ID: 25971370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left atrial voltage during atrial fibrillation in paroxysmal and persistent atrial fibrillation patients.
    Fiala M; Wichterle D; Chovancík J; Bulková V; Wojnarová D; Nevralová R; Januska J
    Pacing Clin Electrophysiol; 2010 May; 33(5):541-8. PubMed ID: 20025720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
    Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does location of epicardial adipose tissue correspond to endocardial high dominant frequency or complex fractionated atrial electrogram sites during atrial fibrillation?
    Nagashima K; Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune M; Mano H; Sonoda K; Hiro T; Nikaido M; Hirayama A
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):676-83. PubMed ID: 22772897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
    Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation.
    Wu CH; Hu YF; Chou CY; Lin YJ; Chang SL; Lo LW; Tuan TC; Li CH; Chao TF; Chung FP; Liao JN; Chen SA
    Heart Rhythm; 2013 Jan; 10(1):10-5. PubMed ID: 22982967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
    Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
    Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-shock sinus node recovery time is an independent predictor of recurrence after catheter ablation of longstanding persistent atrial fibrillation.
    Park J; Shim J; Uhm JS; Joung B; Lee MH; Pak HN
    Int J Cardiol; 2013 Oct; 168(3):1937-42. PubMed ID: 23380697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of metabolic syndrome on left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation.
    Dinov B; Kosiuk J; Kircher S; Bollmann A; Acou WJ; Arya A; Hindricks G; Rolf S
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):483-9. PubMed ID: 24833645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive assessment of left atrial fibrosis. Correlation between echocardiography, biomarkers, and electroanatomical mapping.
    Pilichowska-Paszkiet E; Baran J; Sygitowicz G; Sikorska A; Stec S; Kułakowski P; Zaborska B
    Echocardiography; 2018 Sep; 35(9):1326-1334. PubMed ID: 29900593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of quantification methods for left arial late gadolinium enhancement based on different references in patients with atrial fibrillation.
    Hwang SH; Oh YW; Lee DI; Shim J; Park SW; Kim YH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():91-101. PubMed ID: 25367893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation Between Left Atrial Wall Thickness in Patients with Atrial Fibrillation and Intracardiac Electrogram Characteristics and ATP-Provoked Dormant Pulmonary Vein Conduction.
    Takahashi K; Okumura Y; Watanabe I; Nagashima K; Sonoda K; Sasaki N; Kogawa R; Iso K; Ohkubo K; Nakai T; Hirayama A
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):597-605. PubMed ID: 25777254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation.
    Rolf S; Kircher S; Arya A; Eitel C; Sommer P; Richter S; Gaspar T; Bollmann A; Altmann D; Piedra C; Hindricks G; Piorkowski C
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):825-33. PubMed ID: 25151631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical and substrate abnormalities of the left atrium assessed by 3-dimensional speckle-tracking echocardiography and electroanatomic mapping system in patients with paroxysmal atrial fibrillation.
    Watanabe Y; Nakano Y; Hidaka T; Oda N; Kajihara K; Tokuyama T; Uchimura Y; Sairaku A; Motoda C; Fujiwara M; Kawazoe H; Matsumura H; Kihara Y
    Heart Rhythm; 2015 Mar; 12(3):490-497. PubMed ID: 25485778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of left atrial muscular bundles in catheter ablation of atrial fibrillation.
    Chang SL; Tai CT; Lin YJ; Wongcharoen W; Lo LW; Lee KT; Chang SH; Tuan TC; Chen YJ; Hsieh MH; Tsao HM; Wu MH; Sheu MH; Chang CY; Chen SA
    J Am Coll Cardiol; 2007 Sep; 50(10):964-73. PubMed ID: 17765124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.